尼麦角林对轻度认知损伤患者的干预治疗分析

目的 采用尼麦角林对轻度认知损伤(MCI)患者进行治疗,观察其服药后的认知功能的变化.方法 入选31例MCI患者,尼麦角林组16例,口服尼麦角林10mg,3次/d,连续用药3个月,对照组15例,用药前后均行认知功能评定.结果 与对照组相比,尼麦角林组用药后词语即刻回忆,符号数字转换以及简易智力状态测查的成绩显著提高(P＜0.05).结论 服用尼麦角林对MCI患者的记忆力、注意力有一定改善,进而使MCI患者总体认知功能也有提高.

A sermion interventional study of patients with mild cognitive impairment

Objective To observe the effects of sermion on the cognition status in patients with mild cognitive impairment(MCI)in order to evaluate the significance of interventing MIC with medication.Methods 31 patients with MIC were selected 16 cases were in a treatment group taking sermion for 3 months besides taking basic internal medication and 15 cases in a control group taking only basic internal medication.Before and after treatment,multiple cognition tests were carried out in both groups.Results Verbal instant recall scores,symbol digit modalities test(SDMT)scores and mini-mental state examination(MMSE)total scores in the treatment group were improved significantly after treatment as compared with those in the control group(P<0.05).Conclusion Sermion can improve memory ability as well as attention ability of the patients with MCI to a certain extent and make the general cognition function improved.